Molecular Cancer Therapeutics CTRC-AACR San Antonio Breast Cancer Symposium
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Receive this page by email each issue: [Sign up for eTOCs]

Cover Image
[Cover Caption]
Other Issues:
Contents: September 1 2005, Volume 4, Issue 9   [Index by Author] 
       Articles
       Minireview
       Correction
Find articles in this issue containing these words:
[Search ALL Issues]


To see an article, click its [Full Text] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

Articles:

The rice bran constituent tricin potently inhibits cyclooxygenase enzymes and interferes with intestinal carcinogenesis in ApcMin mice
Hong Cai, Mohammad Al-Fayez, Richard G. Tunstall, Sharon Platton, Peter Greaves, William P. Steward, and Andreas J. Gescher
Mol Cancer Ther 2005 4: 1287-1292. [Abstract] [Full Text] [PDF]  

Tissue transglutaminase 2 inhibition promotes cell death and chemosensitivity in glioblastomas
Liya Yuan, Kihang Choi, Chaitan Khosla, Xiao Zheng, Ryuji Higashikubo, Michael R. Chicoine, and Keith M. Rich
Mol Cancer Ther 2005 4: 1293-1302. [Abstract] [Full Text] [PDF]  

BRAF status and mitogen-activated protein/extracellular signal-regulated kinase kinase 1/2 activity indicate sensitivity of melanoma cells to anthrax lethal toxin
Ralph J. Abi-Habib, Jeffrey O. Urieto, Shihui Liu, Stephen H. Leppla, Nicholas S. Duesbery, and Arthur E. Frankel
Mol Cancer Ther 2005 4: 1303-1310. [Abstract] [Full Text] [PDF]  

Chemical ablation of androgen receptor in prostate cancer cells by the histone deacetylase inhibitor LAQ824
Liwei Chen, Songshu Meng, Hai Wang, Purva Bali, Wenlong Bai, Benyi Li, Peter Atadja, Kapil N. Bhalla, and Jie Wu
Mol Cancer Ther 2005 4: 1311-1319. [Abstract] [Full Text] [PDF]  

Resistance to TRAIL is associated with defects in ceramide signaling that can be overcome by exogenous C6-ceramide without requiring down-regulation of cellular FLICE inhibitory protein
Christina Voelkel-Johnson, Yusuf A. Hannun, and Ahmed El-Zawahry
Mol Cancer Ther 2005 4: 1320-1327. [Abstract] [Full Text] [PDF]  

Potentiation of paclitaxel-induced apoptosis by the novel cyclin-dependent kinase inhibitor NU6140: a possible role for survivin down-regulation
Marzia Pennati, Allyson J. Campbell, Maria Curto, Mara Binda, YuZhu Cheng, Lan-Zeng Wang, Nicola Curtin, Bernard T. Golding, Roger J. Griffin, Ian R. Hardcastle, Andrew Henderson, Nadia Zaffaroni, and David R. Newell
Mol Cancer Ther 2005 4: 1328-1337. [Abstract] [Full Text] [PDF]  

Modulation of cell cycle and gene expression in pancreatic tumor cell lines by methionine deprivation (methionine stress): implications to the therapy of pancreatic adenocarcinoma
Demetrius M. Kokkinakis, XiaoYan Liu, and Russell D. Neuner
Mol Cancer Ther 2005 4: 1338-1348. [Abstract] [Full Text] [PDF] Supplementary Data  

The phosphatidylinositol-3-kinase inhibitor PX-866 overcomes resistance to the epidermal growth factor receptor inhibitor gefitinib in A-549 human non–small cell lung cancer xenografts
Nathan T. Ihle, Gillian Paine-Murrieta, Margareta I. Berggren, Amanda Baker, Wendy R. Tate, Peter Wipf, Robert T. Abraham, D. Lynn Kirkpatrick, and Garth Powis
Mol Cancer Ther 2005 4: 1349-1357. [Abstract] [Full Text] [PDF]  

Cyclooxygenase-independent down-regulation of multidrug resistance–associated protein-1 expression by celecoxib in human lung cancer cells
He-Kyung Kang, Eunmyong Lee, Hongryull Pyo, and Soo-Jeong Lim
Mol Cancer Ther 2005 4: 1358-1363. [Abstract] [Full Text] [PDF]  

Poly(ADP-ribose) polymerase-1 inhibition reverses temozolomide resistance in a DNA mismatch repair–deficient malignant glioma xenograft
C. Lynn Cheng, Stewart P. Johnson, Stephen T. Keir, Jennifer A. Quinn, Francis Ali-Osman, Csaba Szabo, Hongshan Li, Andrew L. Salzman, M. Eileen Dolan, Paul Modrich, Darell D. Bigner, and Henry S. Friedman
Mol Cancer Ther 2005 4: 1364-1368. [Abstract] [Full Text] [PDF]  

An evaluation of the ability of pifithrin-{alpha} and -ß to inhibit p53 function in two wild-type p53 human tumor cell lines
Mike I. Walton, Stuart C. Wilson, Ian R. Hardcastle, Amin R. Mirza, and Paul Workman
Mol Cancer Ther 2005 4: 1369-1377. [Abstract] [Full Text] [PDF]  

Inhibition of human tumor cell growth in vivo by an orally bioavailable inhibitor of CDC25 phosphatases
Marie-Christine Brezak, Muriel Quaranta, Marie-Odile Contour-Galcera, Olivier Lavergne, Odile Mondesert, Pierrïck Auvray, Philip G. Kasprzyk, Gregoire P. Prevost, and Bernard Ducommun
Mol Cancer Ther 2005 4: 1378-1387. [Abstract] [Full Text] [PDF]  

Effects of a series of organosulfur compounds on mitotic arrest and induction of apoptosis in colon cancer cells
Danhua Xiao, John T. Pinto, Gregg G. Gundersen, and I. Bernard Weinstein
Mol Cancer Ther 2005 4: 1388-1398. [Abstract] [Full Text] [PDF]  

Inhibition of invasion, angiogenesis, tumor growth, and metastasis by adenovirus-mediated transfer of antisense uPAR and MMP-9 in non–small cell lung cancer cells
Jasti S. Rao, Christopher Gondi, Chandramu Chetty, Subramanyam Chittivelu, Pushpa A. Joseph, and Sajani S. Lakka
Mol Cancer Ther 2005 4: 1399-1408. [Abstract] [Full Text] [PDF]  

Matrix metalloproteinase inhibitor MMI-166 inhibits lymphogenous metastasis in an orthotopically implanted model of lung cancer
Haruhiko Fujino, Kazuya Kondo, Hisashi Ishikura, Hideo Maki, Hidetaka Kinoshita, Takanori Miyoshi, Yuji Takahashi, Naruhiko Sawada, Hiromitsu Takizawa, Taeko Nagao, Shoji Sakiyama, and Yasumasa Monden
Mol Cancer Ther 2005 4: 1409-1416. [Abstract] [Full Text] [PDF]  

Modulation of intratumoral hypoxia by the epidermal growth factor receptor inhibitor gefitinib detected using small animal PET imaging
Benjamin Solomon, David Binns, Peter Roselt, Leonard I. Weibe, Grant A. McArthur, Carleen Cullinane, and Rodney J. Hicks
Mol Cancer Ther 2005 4: 1417-1422. [Abstract] [Full Text] [PDF]  

Vascular endothelial growth factor selectively targets boronated dendrimers to tumor vasculature
Marina V. Backer, Timur I. Gaynutdinov, Vimal Patel, Achintya K. Bandyopadhyaya, B.T.S. Thirumamagal, Werner Tjarks, Rolf F. Barth, Kevin Claffey, and Joseph M. Backer
Mol Cancer Ther 2005 4: 1423-1429. [Abstract] [Full Text] [PDF]  

Effects of a novel immunomodulating agent, FTY720, on tumor growth and angiogenesis in hepatocellular carcinoma
Joanna W.Y. Ho, Kwan Man, Chris K. Sun, Terence K. Lee, Ronnie T.P. Poon, and Sheung Tat Fan
Mol Cancer Ther 2005 4: 1430-1438. [Abstract] [Full Text] [PDF]  

Low-dose cisplatin protects human neuroblastoma SH-SY5Y cells from paclitaxel-induced apoptosis
Daniela Villa, Mariarosaria Miloso, Gabriella Nicolini, Roberta Rigolio, Antonello Villa, Guido Cavaletti, and Giovanni Tredici
Mol Cancer Ther 2005 4: 1439-1447. [Abstract] [Full Text] [PDF]  

Minireview:

Interaction between epidermal growth factor receptor– and cyclooxygenase 2–mediated pathways and its implications for the chemoprevention of head and neck cancer
Mi Sun Choe, Xin Zhang, Hyung Ju C. Shin, Dong M. Shin, and Zhuo (Georgia) Chen
Mol Cancer Ther 2005 4: 1448-1455. [Abstract] [Full Text] [PDF]  

Correction:

Article on antibody-endostatin fusion protein

Mol Cancer Ther 2005 4: 1456. [Full Text] [PDF]  

To see an article, click its [Full Text] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 2005 by the American Association for Cancer Research.